Brain Cancer News

Sayour’s study, published in Nature, found that COVID mRNA vaccines spark an immune response to fight cancer.

In the lab of MBI researcher Dr. Catherine Flores, M.D.-Ph.D. student Cali Love is developing therapies for glioblastoma.

See highlights stemming from paper published in the journal Nature on Oct. 22.

Organization leads state legislative efforts, champions cancer research, and secures funding to advance the future of oncology and develop tomorrow’s leaders.

In The Conversation, Christiano Marconi discusses a new study in Nature finding that the COVID-19 mRNA vaccine sparks an immune response to fight cancer.

Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who did not get the vaccine, MBI researchers have found.

See highlights stemming from paper published in the journal Nature BME on July 18.

Drs. Jianping Huang and John Ligon have launched a human clinical trial to test an immunotherapy treatment for children with high-grade gliomas.

An experimental mRNA vaccine boosted the tumor-fighting effects of immunotherapy in a mouse-model study, bringing researchers one step closer to their goal of developing a universal vaccine.

Dr. Elias Sayour describes his groundbreaking research to find new treatments for glioblastoma for Inside Precision Medicine.